AGOS PHARMA LIMITED
Opportunity 76/100 (strong), bankability 75/100. Strong seller-intent signal (60/100, director aged 67). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-04-30 | 2024-04-30 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (9 events)Click to expand
- 2026-01-18📄accounts-with-accounts-type-dormantaccounts · AA
- 2025-01-17📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-12-17📄accounts-with-accounts-type-dormantaccounts · AA
- 2022-11-30📄accounts-with-accounts-type-dormantaccounts · AA
- 2022-02-15📄accounts-with-accounts-type-dormantaccounts · AA
- 2020-10-26📄accounts-with-accounts-type-dormantaccounts · AA
- 2019-04-04🏢Company incorporatedAs AGOS PHARMA LIMITED
- 2019-04-04➕KENNERLEY, Peter Mark, Dr appointeddirector
- 2019-04-04📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder age: Director aged approximately 67 — succession pressure is live.
- +No director turnover: Company is 7 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 67. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Peter Mark Kennerley Individual · British · DOB 11/1959 · age 67 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 04/04/2019 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · SG postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AJ ISHERWOOD CONSULTING LTD→ 10975215 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AJAX CONSULTING LIMITED→ 16388730 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AJL WAREHOUSING LTD→ 16791145 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ALAN MICHAEL BAXTER CONSULTING LIMITED→ 16730310 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ALBB CONSULTING LTD→ 15713395 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALDERAAN-LABS LIMITED→ 17105927 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALEMANIA LIMITED→ 11468625 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ALEXANDER CONSULTING (UK) LTD→ 09106353 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ALEXANDER HOLNESS LTD→ 11653289 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ALEXANDER-WATSON CONSULTING LTD→ 13971519 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ALFA LEADERSHIP & WELLBEING LTD→ 15191009 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ALL 2 GAIN LIMITED→ 14896310 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.